Etranacogene dezaparvovec meets the benchmarks for success, researcher says ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained endogenous factor IX expression and low annualized bleeding rates over five ...

For men with hemophilia B, receipt of gene therapy comprising an infusion of etranacogene dezaparvovec results in sustained ...

DecisionDx-Melanoma demonstrates robust clinical utility and validated performance, supported by high-quality (SORT A) ...

Florida dolphins exposed to algal bloom toxins show brain changes similar to Alzheimer's patients, raising concerns for ...

The inaugural competition surprisingly awarded two $100,000 grand prizes to address challenges in defining robust benchmarks for complex biology.

Cancer isn't just about broken genes-it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off neighborhoods from essential services. That's what happens inside cells ...

Institute of Neuroscience, Howard Hughes Medical Institute, University of Oregon, Eugene, United States ...

Pooled data from 3 phase III clinical trial shows that the addition of neoadjuvant carboplatin to chemotherapy improves outcomes for patients with early-stage triple-negative breast cancer.

Egg-based antibody demonstrated significant improvements in poultry livability and feed efficiency across commercial broiler, ...

Drug aims to correct genetic defect ...

The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...